Showing results (131-140 of 176) with videos related to

Sort By:
Pageof 18
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 12, 2021
Content of Health Economics Analysis Plans (HEAPs) for Trial-Based Economic Evaluations: Expert Delphi Consensus SurveyJoanna C Thorn, Charlotte F Davies, Sara T Brookes, et al.
Health Technology Assessment (Winchester, England)|July 12, 2023
Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studiesJessica Harris, Koen B Pouwels, Thomas Johnson, et al.
Health Technology Assessment (Winchester, England)|November 5, 2016
The Effectiveness, cost-effectiveness and acceptability of Community versus Hospital Eye Service follow-up for patients with neovascular age-related macular degeneration with quiescent disease (ECHoES): a virtual randomised balanced incomplete block trialBarnaby C Reeves, Lauren J Scott, Jodi Taylor, et al.
Resuscitation|November 7, 2016
Design and implementation of the AIRWAYS-2 trial: A multi-centre cluster randomised controlled trial of the clinical and cost effectiveness of the i-gel supraglottic airway device versus tracheal intubation in the initial airway management of out of hospital cardiac arrestJodi Taylor, Sarah Black, Stephen J Brett, et al.
Plos Medicine|February 15, 2017
Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health ServiceAngela Hamblin, Sarah Wordsworth, Jilles M Fermont, et al.
Lancet (London, England)|June 14, 2024
Stereotactic radiotherapy for neovascular age-related macular degeneration (STAR): a pivotal, randomised, double-masked, sham-controlled device trialTimothy L Jackson, Riti Desai, Hatem A Wafa, et al.
BMJ (Clinical Research Ed.)|June 18, 2026
Stereotactic radiotherapy for neovascular age related macular degeneration: year 3 and 4 extended follow up results of a randomised, double masked, sham controlled, device trial (STAR)Timothy L Jackson, Riti Desai, Hatem A Wafa, et al.
Health Technology Assessment (Winchester, England)|October 8, 2015
A randomised controlled trial to assess the clinical effectiveness and cost-effectiveness of alternative treatments to Inhibit VEGF in Age-related choroidal Neovascularisation (IVAN)Usha Chakravarthy, Simon P Harding, Chris A Rogers, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 17, 2003
Early referral and planned initiation of dialysis: what impact on quality of life?Fergus J Caskey, Sarah Wordsworth, Thomas Ben, et al.
BMC Medicine|April 24, 2020
Reducing expectations for antibiotics in primary care: a randomised experiment to test the response to fear-based messages about antimicrobial resistanceLaurence S J Roope, Sarah Tonkin-Crine, Natalie Herd, et al.
Pageof 18